BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7814817)

  • 1. Normal technetium 99m diphosphonate bone scintigraphy in skeletal metastases from hepatocellular carcinoma.
    Maillefert JF; Tebib J; Quipourt V; Brunotte F; Michiels C; Hillon P; Tavernier C
    J Hepatol; 1994 Oct; 21(4):684. PubMed ID: 7814817
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical usefulness of 123I-IMP scintigraphy in the diagnosis of bone metastases from hepatocellular carcinoma: comparison with 99mTc-MDP bone scintigraphy].
    Suto Y; Tanigawa N; Iwamiya T; Kato T; Endo K; Shabana M; Ohta Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Aug; 53(8):953-9. PubMed ID: 8396760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Radiological diagnosis of bone metastasis of hepatoma].
    Nakata H; Kaneko K; Nakayama C; Kimoto T; Nakayama T
    Rinsho Hoshasen; 1984 Aug; 29(8):855-8. PubMed ID: 6096597
    [No Abstract]   [Full Text] [Related]  

  • 4. Tc-99m PMT whole-body scintigraphy for evaluated of therapeutic effect and for monitoring bone metastasis in a patient with hepatocellular carcinoma.
    Sueyoshi K; Narabayashi I; Doi K; Takahashi M; Komori T; Tatsu Y; Tatsumi T; Utunomiya K; Uesugi Y; Adachi I; Shimizu T
    Clin Nucl Med; 2000 Dec; 25(12):1000-3. PubMed ID: 11129132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous hot and cold bone scan metastases in hepatocellular carcinoma.
    Leung CM; Stewart IE; Metreweli C
    Clin Nucl Med; 1995 Sep; 20(9):839. PubMed ID: 8521667
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of bone, gallium and hepatobiliary scintigraphy in the detection of bone metastases in hepatoma].
    Tahara T; Ichiya Y; Kuwabara Y; Otsuka M; Masuda K
    Kaku Igaku; 1988 Dec; 25(12):1337-44. PubMed ID: 2854867
    [No Abstract]   [Full Text] [Related]  

  • 7. Scintigraphic "doughnut sign" on bone scintigraphy secondary to metastatic hepatocellular carcinoma.
    Hirano T; Otake H; Kanuma M; Mogi Y; Tatezawa T
    Clin Nucl Med; 1995 Nov; 20(11):1020-1. PubMed ID: 8565359
    [No Abstract]   [Full Text] [Related]  

  • 8. Utility of Tc-99m GSA whole-body scintigraphy in detecting bone metastases from hepatocellular carcinoma.
    Sueyoshi K; Narabayashi I; Aratani T; Doi K; Komori T; Ogura Y; Utsunomiya K; Shimidzu T
    Clin Nucl Med; 2001 Mar; 26(3):221-4. PubMed ID: 11245114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing the performance and interpretation of bone scans.
    Muroff LR
    Clin Nucl Med; 1981 Oct; 6(10S):P68-76. PubMed ID: 6271444
    [No Abstract]   [Full Text] [Related]  

  • 10. Value of pre-treatment and follow-up skeletal scintigraphy in operable breast cancer.
    Pauwels EK; Heslinga JM; Zwaveling A
    Clin Oncol; 1982 Mar; 8(1):25-32. PubMed ID: 6280915
    [No Abstract]   [Full Text] [Related]  

  • 11. High false negative rate of Tc-99m MDP whole-body bone scintigraphy in detecting skeletal metastases for patients with hepatoma.
    Chen CY; Wu K; Lin WH; Lan TY; Wang SY; Sun JS; Weng PW; Yen RF; Yang RS
    J Formos Med Assoc; 2012 Mar; 111(3):140-6. PubMed ID: 22423667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential use of I-123 IMP scintigraphy for pelvic bone metastases in hepatocellular carcinoma. A comparison with Ga-67 scintigraphy.
    Suto Y; Tanigawa N; Iwamiya T; Shabana M; Ohta Y
    Clin Nucl Med; 1994 Apr; 19(4):302-6. PubMed ID: 8004860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radionuclide bone imaging.
    Bassett LW; Gold RH; Webber MM
    Radiol Clin North Am; 1981 Dec; 19(4):675-702. PubMed ID: 7034044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Investigation of 99mTc-methylene diphosphonate scintigraphy of patients with lung cancer].
    Abe M; Ohde R; Ogata T; Kawaguchi S; Kikuchi K; Kawai T; Matsuzawa K; Takanoshi H
    Rinsho Hoshasen; 1982 Jun; 27(6):621-5. PubMed ID: 6292553
    [No Abstract]   [Full Text] [Related]  

  • 15. Incidental finding of a hepatic lesion: differential diagnostic problems for fibrolamellar hepatic carcinoma.
    Reuland P; Aicher KP; Brambs HJ; Enderle G; Feine U; Gärtner HV; Weber P
    J Nucl Med; 1994 Aug; 35(8):1342-6. PubMed ID: 8046491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of bone scans in the initial assessment of operable patients with breast carcinoma.
    Strender LE; Lagergren C; Wallgren A; Liljevall S
    Acta Radiol Oncol; 1981; 20(3):187-91. PubMed ID: 6270978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photon-deficient bone metastases in hepatocellular carcinoma.
    Ikehira H; Furuichi Y; Mizuno S; Segawa H; Nakamura H; Kimura S; Yamamoto S; Takano H; Ito H; Aoki T
    Clin Nucl Med; 1998 May; 23(5):329-30. PubMed ID: 9596165
    [No Abstract]   [Full Text] [Related]  

  • 18. Uptake of technetium-99m DISIDA by bone metastasis from a hepatoma.
    Pons F; Lomeña F; Calvet X; Bruix J; Catafau A; Ginés A; Herranz R; Setoain J
    Clin Nucl Med; 1988 Apr; 13(4):280-2. PubMed ID: 2836119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple bone metastases of hepatocellular carcinoma.
    Kubota T
    Ann Nucl Med; 2001 Dec; 15(6):front cover, 520. PubMed ID: 11831405
    [No Abstract]   [Full Text] [Related]  

  • 20. [Usefulness of 99mTc-PMT cholescintigraphy in diagnosis a case of bone metastasis in hepatocellular carcinoma].
    Inoue A; Imaeda T; Yanagawa S; Doi T
    Rinsho Hoshasen; 1989 Aug; 34(8):901-2. PubMed ID: 2555595
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.